The concept of perihilar cholangiocarcinoma is valid

被引:91
作者
Ebata, T.
Kamiya, J.
Nishio, H.
Nagasaka, T. [2 ]
Nimura, Y. [3 ]
Nagino, M. [1 ]
机构
[1] Nagoya Univ, Dept Surg, Div Surg Oncol, Grad Sch Med,Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Dept Clin Physiopathol, Grad Sch Med, Nagoya, Aichi 4668550, Japan
[3] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
关键词
BILE-DUCT CARCINOMA; FORMING INTRAHEPATIC CHOLANGIOCARCINOMA; HILAR CHOLANGIOCARCINOMA; PORTAL-VEIN; STAGING SYSTEM; EXTENDED HEPATECTOMY; SURGICAL RESECTION; LIVER RESECTION; HEPATIC HILUS; UNITED-STATES;
D O I
10.1002/bjs.6655
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The term perihilar cholangiocarcinoma has been used for all rumours involving or requiring resection of the hepatic confluence. However, it does not distinguish between intrahepatic and extrahepatic hilar tumours, and has no clinicopathological basis. This retrospective study examined whether the concept of perihilar cholangiocarcinoma is valid clinically. Methods: Some 250 patients with perihilar cholangiocarcinoma were divided into extrahepatic (EHC, 167 patients) and intrahepatic (IHC, 83) groups based on tumour location. Clinicopathological data were compared between these groups. Results: Liver, portal vein, venous and lymphatic invasion, and nodal metastasis were more common in IHCs than EHCs, whereas histological grade and incidence of perineural invasion were similar. IHCs were more advanced at the time of surgery; stage III or IV disease was found in 37.7 per cent of EHCs and 59 per cent of IHCs. Survival was marginally better for patients with EHCs than for those with IHCs (29.3 versus 20 per cent at 5 years; P = 0.057), but survival rates were similar for each tumour stage in the American joint Committee on Cancer classification. Conclusion: Combining EHC and IHC under the term perihilar cholangiocarcinoma is valid, as these tumours have comparable biological behaviour, with similar clinical management depending on stage and invasion.
引用
收藏
页码:926 / 934
页数:9
相关论文
共 46 条
[1]  
BHUIYA MMR, 1992, ANN SURG, V215, P344
[2]   MANAGEMENT STRATEGIES IN RESECTION FOR HILAR CHOLANGIOCARCINOMA [J].
BISMUTH, H ;
NAKACHE, R ;
DIAMOND, T .
ANNALS OF SURGERY, 1992, 215 (01) :31-38
[3]  
Burke EC, 1998, ANN SURG, V228, P385, DOI 10.1097/00000658-199809000-00011
[4]   ENDOSCOPIC BILIARY THERAPY USING THE COMBINED PERCUTANEOUS AND ENDOSCOPIC TECHNIQUE [J].
DOWSETT, JF ;
VAIRA, D ;
HATFIELD, ARW ;
CAIRNS, SR ;
POLYDOROU, A ;
FROST, R ;
CROKER, J ;
COTTON, PB ;
RUSSELL, RCG ;
MASON, RR .
GASTROENTEROLOGY, 1989, 96 (04) :1180-1186
[5]   Hepatectomy with portal vein resection for hilar cholangiocarcinoma - Audit of 52 consecutive cases [J].
Ebata, T ;
Nagino, M ;
Kamiya, J ;
Uesaka, K ;
Nagasaka, T ;
Nimura, Y .
ANNALS OF SURGERY, 2003, 238 (05) :720-727
[6]   Pathological appraisal of lines of resection for bile duct carcinoma [J].
Ebata, T ;
Watanabe, H ;
Ajioka, Y ;
Oda, K ;
Nimura, Y .
BRITISH JOURNAL OF SURGERY, 2002, 89 (10) :1260-1267
[7]  
Greene FL., 2002, AJCC CANC STAGING HD, V6th
[8]  
Hamilton SR., 2000, WHO CLASSIFICATION T
[9]  
Henson DE, 2000, ARCH PATHOL LAB MED, V124, P26
[10]  
Hirohashi Kazuhiro, 2002, J Hepatobiliary Pancreat Surg, V9, P233, DOI 10.1007/s005340200024